Literature DB >> 23217614

NK cells controlling virus-specific T cells: Rheostats for acute vs. persistent infections.

Raymond M Welsh1, Stephen N Waggoner.   

Abstract

Viral infections characteristically induce a cytokine-driven activated natural killer (NK) cell response that precedes an antigen-driven T cell response. These NK cells can restrain some but not all viral infections by attacking virus-infected cells and can thereby provide time for an effective T cell response to mobilize. Recent studies have revealed an additional immunoregulatory role for the NK cells, where they inhibit the size and functionality of the T cell response, regardless of whether the viruses are themselves sensitive to NK cells. This subsequent change in T cell dynamics can alter patterns of immunopathology and persistence and implicates NK cells as rheostat-like regulators of persistent infections.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23217614      PMCID: PMC3521501          DOI: 10.1016/j.virol.2012.10.005

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  91 in total

1.  The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells.

Authors:  G B Cohen; R T Gandhi; D M Davis; O Mandelboim; B K Chen; J L Strominger; D Baltimore
Journal:  Immunity       Date:  1999-06       Impact factor: 31.745

2.  The murine homologue of the human NKp46, a triggering receptor involved in the induction of natural cytotoxicity.

Authors:  R Biassoni; A Pessino; C Bottino; D Pende; L Moretta; A Moretta
Journal:  Eur J Immunol       Date:  1999-03       Impact factor: 5.532

3.  Down-regulation of the expression and function of the transporter associated with antigen processing in murine tumor cell lines expressing IL-10.

Authors:  F Salazar-Onfray; J Charo; M Petersson; S Freland; G Noffz; Z Qin; T Blankenstein; H G Ljunggren; R Kiessling
Journal:  J Immunol       Date:  1997-10-01       Impact factor: 5.422

Review 4.  NK cell receptors.

Authors:  L L Lanier
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

Review 5.  The natural killer gene complex: a genetic basis for understanding natural killer cell function and innate immunity.

Authors:  M G Brown; A A Scalzo; K Matsumoto; W M Yokoyama
Journal:  Immunol Rev       Date:  1997-02       Impact factor: 12.988

6.  Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1.

Authors:  Roi Gazit; Raizy Gruda; Moran Elboim; Tal I Arnon; Gil Katz; Hagit Achdout; Jacob Hanna; Udi Qimron; Guy Landau; Evgenia Greenbaum; Zichria Zakay-Rones; Angel Porgador; Ofer Mandelboim
Journal:  Nat Immunol       Date:  2006-03-26       Impact factor: 25.606

7.  Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells.

Authors:  C H Tay; R M Welsh
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

8.  Restoring function in exhausted CD8 T cells during chronic viral infection.

Authors:  Daniel L Barber; E John Wherry; David Masopust; Baogong Zhu; James P Allison; Arlene H Sharpe; Gordon J Freeman; Rafi Ahmed
Journal:  Nature       Date:  2005-12-28       Impact factor: 49.962

9.  Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus.

Authors:  W Cao; M D Henry; P Borrow; H Yamada; J H Elder; E V Ravkov; S T Nichol; R W Compans; K P Campbell; M B Oldstone
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

10.  Viral immune evasion due to persistence of activated T cells without effector function.

Authors:  A J Zajac; J N Blattman; K Murali-Krishna; D J Sourdive; M Suresh; J D Altman; R Ahmed
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307

View more
  41 in total

Review 1.  Boosting vaccine efficacy the natural (killer) way.

Authors:  Carolyn E Rydyznski; Stephen N Waggoner
Journal:  Trends Immunol       Date:  2015-08-10       Impact factor: 16.687

Review 2.  Tropism of human pegivirus (formerly known as GB virus C/hepatitis G virus) and host immunomodulation: insights into a highly successful viral infection.

Authors:  Ernest T Chivero; Jack T Stapleton
Journal:  J Gen Virol       Date:  2015-02-09       Impact factor: 3.891

Review 3.  Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells.

Authors:  Barbara Rehermann
Journal:  Nat Med       Date:  2013-07       Impact factor: 53.440

4.  Licensed human natural killer cells aid dendritic cell maturation via TNFSF14/LIGHT.

Authors:  Tim D Holmes; Erica B Wilson; Emma V I Black; Andrew V Benest; Candida Vaz; Betty Tan; Vivek M Tanavde; Graham P Cook
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-15       Impact factor: 11.205

5.  Cytokine-Mediated Activation of NK Cells during Viral Infection.

Authors:  Bailey E Freeman; Hans-Peter Raué; Ann B Hill; Mark K Slifka
Journal:  J Virol       Date:  2015-05-20       Impact factor: 5.103

Review 6.  T cell exhaustion during persistent viral infections.

Authors:  Shannon M Kahan; E John Wherry; Allan J Zajac
Journal:  Virology       Date:  2015-01-22       Impact factor: 3.616

Review 7.  Optimizing intracellular signaling domains for CAR NK cells in HIV immunotherapy: a comprehensive review.

Authors:  Giorgio Zenere; Omalla Allan Olwenyi; Siddappa N Byrareddy; Stephen E Braun
Journal:  Drug Discov Today       Date:  2019-02-13       Impact factor: 7.851

8.  Therapeutic depletion of natural killer cells controls persistent infection.

Authors:  Stephen N Waggoner; Keith A Daniels; Raymond M Welsh
Journal:  J Virol       Date:  2013-11-27       Impact factor: 5.103

Review 9.  Innate and Adaptive Immune Responses in Chronic HCV Infection.

Authors:  Lynn B Dustin
Journal:  Curr Drug Targets       Date:  2017       Impact factor: 3.465

Review 10.  Immune control and failure in HCV infection--tipping the balance.

Authors:  Lynn B Dustin; Siobhán B Cashman; Stephen M Laidlaw
Journal:  J Leukoc Biol       Date:  2014-07-11       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.